A
Akari Therapeutics (AKTX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Akari Therapeutics (AKTX)
Akari Therapeutics, Plc is a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases. The Company's lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activati... Read more
- USD1.16
- USD1.18
- USD1.16
- USD4.40
- -8.00%
- --
- 8.22k
- 21.58k
- 37M
- 0.85
- -55.90%
Stock News
3 hours ago
DRC Medicine Ltd. Announces the Business Combination Agreement with Ribbon Acquisition Corp.
Yahoo
yesterday
Jim Cramer explains how younger buyers are driving market action
CNBC
yesterday
Despite tariffs, Andy Jassy says Amazon hasn't 'seen prices appreciably go up,' so far
CNBC
yesterday
Cristiano Ronaldo’s new $700 million contract reportedly includes private-jet credits and personal staff. Here’s how that compares with perks for other top athletes and CEOs.
MarketWatch
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
